Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophore modeling

MLA

Liana Ghasemi, et al. “Synthesis and Characterization of Two New Mixed-Ligand Cu(II) Complexes of a Tridentate NN’O Type Schiff Base Ligand and N-Donor Heterocyclic Co-Ligands: In Vitro Anticancer Assay, DNA/Human Leukemia/COVID-19 Molecular Docking Studies, and Pharmacophore Modeling.” Applied Organometallic Chemistry, vol. 36, no. 5, Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ddd9f64222f1a65c1ea07f8ddbba5b81&authtype=sso&custid=ns315887.

APA

Liana Ghasemi, Mahdi Behzad, Ali Khaleghian, Alireza Abbasi, & Anita Abedi. (2021). Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN’O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophore modeling. Applied Organometallic Chemistry, 36(5).

Chicago

Liana Ghasemi, Mahdi Behzad, Ali Khaleghian, Alireza Abbasi, and Anita Abedi. 2021. “Synthesis and Characterization of Two New Mixed-Ligand Cu(II) Complexes of a Tridentate NN’O Type Schiff Base Ligand and N-Donor Heterocyclic Co-Ligands: In Vitro Anticancer Assay, DNA/Human Leukemia/COVID-19 Molecular Docking Studies, and Pharmacophore Modeling.” Applied Organometallic Chemistry 36 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ddd9f64222f1a65c1ea07f8ddbba5b81&authtype=sso&custid=ns315887.